Vanguard Group’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.6M Sell
2,278,465
-113,587
-5% -$1.48M ﹤0.01% 2371
2025
Q1
$60.4M Buy
2,392,052
+8,504
+0.4% +$215K ﹤0.01% 2015
2024
Q4
$81.9M Buy
2,383,548
+96,464
+4% +$3.32M ﹤0.01% 1948
2024
Q3
$113M Buy
2,287,084
+279,146
+14% +$13.8M ﹤0.01% 1820
2024
Q2
$121M Buy
2,007,938
+483,428
+32% +$29.1M ﹤0.01% 1748
2024
Q1
$78.6M Buy
1,524,510
+40,500
+3% +$2.09M ﹤0.01% 1978
2023
Q4
$59.8M Buy
1,484,010
+50,057
+3% +$2.02M ﹤0.01% 2112
2023
Q3
$40M Buy
1,433,953
+255,150
+22% +$7.12M ﹤0.01% 2236
2023
Q2
$33.9M Buy
1,178,803
+159,310
+16% +$4.59M ﹤0.01% 2361
2023
Q1
$17M Buy
1,019,493
+223,228
+28% +$3.72M ﹤0.01% 2662
2022
Q4
$10.1M Sell
796,265
-6,484
-0.8% -$82.2K ﹤0.01% 2943
2022
Q3
$9.63M Buy
802,749
+130,694
+19% +$1.57M ﹤0.01% 2968
2022
Q2
$9.46M Buy
672,055
+33,242
+5% +$468K ﹤0.01% 3018
2022
Q1
$7.91M Buy
638,813
+301,055
+89% +$3.73M ﹤0.01% 3277
2021
Q4
$3.8M Sell
337,758
-69,795
-17% -$785K ﹤0.01% 3765
2021
Q3
$5.16M Buy
+407,553
New +$5.16M ﹤0.01% 3637